Slide
Centre Interdisciplinaire
de Recherche et d’Innovation
en Cybersécurité et Société
de Recherche et d’Innovation
en Cybersécurité et Société
1.
Bouchard, S.; Pessanha, C. Torres; Tober, K. H.
Assessing telepresence when delivering psychotherapy in videoconference: relevance and test-retest reliability of the Telepresence Videoconference Scale Article de journal
Dans: Annual Review of CyberTherapy and Telemedicine, vol. 23, p. 70–75, 2025, ISSN: 15548716 (ISSN).
Résumé | Liens | BibTeX | Étiquettes: adult, agoraphobia, article, Client Satisfaction Questionnaire, cognitive behavioral therapy, discriminant validity, female, generalized anxiety disorder, human, major clinical study, male, panic, Patient Satisfaction, psychological rating scale, psychotherapy, questionnaire, social interaction, Telemedicine, telepresence, Telepresence in Videoconference Scale, Telepresence Videoconference Scale, telepsychotherapy, test retest reliability, Test-retest reliability, videoconference, videoconferencing
@article{bouchard_assessing_2025,
title = {Assessing telepresence when delivering psychotherapy in videoconference: relevance and test-retest reliability of the Telepresence Videoconference Scale},
author = {S. Bouchard and C. Torres Pessanha and K. H. Tober},
url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-105023903509&partnerID=40&md5=46afce3aea732a9501fc3a1096d67673},
issn = {15548716 (ISSN)},
year = {2025},
date = {2025-01-01},
journal = {Annual Review of CyberTherapy and Telemedicine},
volume = {23},
pages = {70–75},
abstract = {The increasing use of psychotherapy delivered via videoconference requires sound methods to assess clients' subjective experiences. Telepresence, defined as the feeling of being together in an online session despite the actual physical distance, is receiving increased attention as an important concept. The Telepresence in Videoconference Scale (TVS) assesses client telepresence during psychotherapy sessions and has been initially validated. However, its stability across sessions and its independence from the concept of treatment satisfaction need further evaluation. This paper presents an overview of studies using the TVS and examines the psychometric properties of the TVS in 65 adults (mean age = 39.9},
keywords = {adult, agoraphobia, article, Client Satisfaction Questionnaire, cognitive behavioral therapy, discriminant validity, female, generalized anxiety disorder, human, major clinical study, male, panic, Patient Satisfaction, psychological rating scale, psychotherapy, questionnaire, social interaction, Telemedicine, telepresence, Telepresence in Videoconference Scale, Telepresence Videoconference Scale, telepsychotherapy, test retest reliability, Test-retest reliability, videoconference, videoconferencing},
pubstate = {published},
tppubtype = {article}
}
The increasing use of psychotherapy delivered via videoconference requires sound methods to assess clients' subjective experiences. Telepresence, defined as the feeling of being together in an online session despite the actual physical distance, is receiving increased attention as an important concept. The Telepresence in Videoconference Scale (TVS) assesses client telepresence during psychotherapy sessions and has been initially validated. However, its stability across sessions and its independence from the concept of treatment satisfaction need further evaluation. This paper presents an overview of studies using the TVS and examines the psychometric properties of the TVS in 65 adults (mean age = 39.9
2.
Bouchard, S.; Pessanha, C. Torres; Tober, K. H.
Assessing telepresence when delivering psychotherapy in videoconference: relevance and test-retest reliability of the Telepresence Videoconference Scale Article de journal
Dans: Annual Review of CyberTherapy and Telemedicine, vol. 23, p. 70–75, 2025, ISSN: 15548716 (ISSN).
Résumé | Liens | BibTeX | Étiquettes: adult, agoraphobia, article, Client Satisfaction Questionnaire, cognitive behavioral therapy, discriminant validity, female, generalized anxiety disorder, human, major clinical study, male, panic, Patient Satisfaction, psychological rating scale, psychotherapy, questionnaire, social interaction, Telemedicine, telepresence, Telepresence in Videoconference Scale, Telepresence Videoconference Scale, telepsychotherapy, test retest reliability, Test-retest reliability, videoconference, videoconferencing
@article{bouchardAssessingTelepresenceWhen2025,
title = {Assessing telepresence when delivering psychotherapy in videoconference: relevance and test-retest reliability of the Telepresence Videoconference Scale},
author = {S. Bouchard and C. Torres Pessanha and K. H. Tober},
url = {https://www.scopus.com/pages/publications/105023903509?origin=resultslist},
issn = {15548716 (ISSN)},
year = {2025},
date = {2025-01-01},
journal = {Annual Review of CyberTherapy and Telemedicine},
volume = {23},
pages = {70–75},
publisher = {Interactive Media Institute},
abstract = {The increasing use of psychotherapy delivered via videoconference requires sound methods to assess clients' subjective experiences. Telepresence, defined as the feeling of being together in an online session despite the actual physical distance, is receiving increased attention as an important concept. The Telepresence in Videoconference Scale (TVS) assesses client telepresence during psychotherapy sessions and has been initially validated. However, its stability across sessions and its independence from the concept of treatment satisfaction need further evaluation. This paper presents an overview of studies using the TVS and examines the psychometric properties of the TVS in 65 adults (mean age = 39.9},
keywords = {adult, agoraphobia, article, Client Satisfaction Questionnaire, cognitive behavioral therapy, discriminant validity, female, generalized anxiety disorder, human, major clinical study, male, panic, Patient Satisfaction, psychological rating scale, psychotherapy, questionnaire, social interaction, Telemedicine, telepresence, Telepresence in Videoconference Scale, Telepresence Videoconference Scale, telepsychotherapy, test retest reliability, Test-retest reliability, videoconference, videoconferencing},
pubstate = {published},
tppubtype = {article}
}
The increasing use of psychotherapy delivered via videoconference requires sound methods to assess clients' subjective experiences. Telepresence, defined as the feeling of being together in an online session despite the actual physical distance, is receiving increased attention as an important concept. The Telepresence in Videoconference Scale (TVS) assesses client telepresence during psychotherapy sessions and has been initially validated. However, its stability across sessions and its independence from the concept of treatment satisfaction need further evaluation. This paper presents an overview of studies using the TVS and examines the psychometric properties of the TVS in 65 adults (mean age = 39.9
3.
Bouchard, S.; Pessanha, C. Torres; Tober, K. H.
Assessing telepresence when delivering psychotherapy in videoconference: relevance and test-retest reliability of the Telepresence Videoconference Scale Article de journal
Dans: Annual Review of CyberTherapy and Telemedicine, vol. 23, p. 70–75, 2025, ISSN: 15548716 (ISSN).
Résumé | Liens | BibTeX | Étiquettes: adult, agoraphobia, article, Client Satisfaction Questionnaire, cognitive behavioral therapy, discriminant validity, female, generalized anxiety disorder, human, major clinical study, male, panic, Patient Satisfaction, psychological rating scale, psychotherapy, questionnaire, social interaction, Telemedicine, telepresence, Telepresence in Videoconference Scale, Telepresence Videoconference Scale, telepsychotherapy, test retest reliability, Test-retest reliability, videoconference, videoconferencing
@article{bouchardAssessingTelepresenceWhen2025a,
title = {Assessing telepresence when delivering psychotherapy in videoconference: relevance and test-retest reliability of the Telepresence Videoconference Scale},
author = {S. Bouchard and C. Torres Pessanha and K. H. Tober},
url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-105023903509&partnerID=40&md5=46afce3aea732a9501fc3a1096d67673},
issn = {15548716 (ISSN)},
year = {2025},
date = {2025-01-01},
journal = {Annual Review of CyberTherapy and Telemedicine},
volume = {23},
pages = {70–75},
abstract = {The increasing use of psychotherapy delivered via videoconference requires sound methods to assess clients' subjective experiences. Telepresence, defined as the feeling of being together in an online session despite the actual physical distance, is receiving increased attention as an important concept. The Telepresence in Videoconference Scale (TVS) assesses client telepresence during psychotherapy sessions and has been initially validated. However, its stability across sessions and its independence from the concept of treatment satisfaction need further evaluation. This paper presents an overview of studies using the TVS and examines the psychometric properties of the TVS in 65 adults (mean age = 39.9},
keywords = {adult, agoraphobia, article, Client Satisfaction Questionnaire, cognitive behavioral therapy, discriminant validity, female, generalized anxiety disorder, human, major clinical study, male, panic, Patient Satisfaction, psychological rating scale, psychotherapy, questionnaire, social interaction, Telemedicine, telepresence, Telepresence in Videoconference Scale, Telepresence Videoconference Scale, telepsychotherapy, test retest reliability, Test-retest reliability, videoconference, videoconferencing},
pubstate = {published},
tppubtype = {article}
}
The increasing use of psychotherapy delivered via videoconference requires sound methods to assess clients' subjective experiences. Telepresence, defined as the feeling of being together in an online session despite the actual physical distance, is receiving increased attention as an important concept. The Telepresence in Videoconference Scale (TVS) assesses client telepresence during psychotherapy sessions and has been initially validated. However, its stability across sessions and its independence from the concept of treatment satisfaction need further evaluation. This paper presents an overview of studies using the TVS and examines the psychometric properties of the TVS in 65 adults (mean age = 39.9
4.
Bouchard, S.; Pessanha, C. Torres; Tober, K. H.
Assessing telepresence when delivering psychotherapy in videoconference: relevance and test-retest reliability of the Telepresence Videoconference Scale Article de journal
Dans: Annual Review of CyberTherapy and Telemedicine, vol. 23, p. 70–75, 2025, ISSN: 15548716 (ISSN).
Résumé | Liens | BibTeX | Étiquettes: adult, agoraphobia, article, Client Satisfaction Questionnaire, cognitive behavioral therapy, discriminant validity, female, generalized anxiety disorder, human, major clinical study, male, panic, Patient Satisfaction, psychological rating scale, psychotherapy, questionnaire, social interaction, Telemedicine, telepresence, Telepresence in Videoconference Scale, Telepresence Videoconference Scale, telepsychotherapy, test retest reliability, Test-retest reliability, videoconference, videoconferencing
@article{bouchardAssessingTelepresenceWhen2025b,
title = {Assessing telepresence when delivering psychotherapy in videoconference: relevance and test-retest reliability of the Telepresence Videoconference Scale},
author = {S. Bouchard and C. Torres Pessanha and K. H. Tober},
url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-105023903509&partnerID=40&md5=46afce3aea732a9501fc3a1096d67673},
issn = {15548716 (ISSN)},
year = {2025},
date = {2025-01-01},
journal = {Annual Review of CyberTherapy and Telemedicine},
volume = {23},
pages = {70–75},
abstract = {The increasing use of psychotherapy delivered via videoconference requires sound methods to assess clients' subjective experiences. Telepresence, defined as the feeling of being together in an online session despite the actual physical distance, is receiving increased attention as an important concept. The Telepresence in Videoconference Scale (TVS) assesses client telepresence during psychotherapy sessions and has been initially validated. However, its stability across sessions and its independence from the concept of treatment satisfaction need further evaluation. This paper presents an overview of studies using the TVS and examines the psychometric properties of the TVS in 65 adults (mean age = 39.9},
keywords = {adult, agoraphobia, article, Client Satisfaction Questionnaire, cognitive behavioral therapy, discriminant validity, female, generalized anxiety disorder, human, major clinical study, male, panic, Patient Satisfaction, psychological rating scale, psychotherapy, questionnaire, social interaction, Telemedicine, telepresence, Telepresence in Videoconference Scale, Telepresence Videoconference Scale, telepsychotherapy, test retest reliability, Test-retest reliability, videoconference, videoconferencing},
pubstate = {published},
tppubtype = {article}
}
The increasing use of psychotherapy delivered via videoconference requires sound methods to assess clients' subjective experiences. Telepresence, defined as the feeling of being together in an online session despite the actual physical distance, is receiving increased attention as an important concept. The Telepresence in Videoconference Scale (TVS) assesses client telepresence during psychotherapy sessions and has been initially validated. However, its stability across sessions and its independence from the concept of treatment satisfaction need further evaluation. This paper presents an overview of studies using the TVS and examines the psychometric properties of the TVS in 65 adults (mean age = 39.9
5.
Bouchard, S.; Berthiaume, M.; Robillard, G.; Allard, M.; Green-Demers, I.; Watts, S.; Marchand, A.; Gosselin, P.; Langlois, F.; Belleville, G.; Dugas, M. J.
The moderating and mediating role of telepresence and cognitive change in cognitive behaviour therapy delivered via videoconference Article de journal
Dans: Clinical Psychology and Psychotherapy, vol. 30, no 3, p. 575–586, 2023, ISSN: 10633995, (Publisher: John Wiley and Sons Ltd).
Résumé | Liens | BibTeX | Étiquettes: agoraphobia, Anxiety disorder, Anxiety Disorders, cognition, cognitive behavioral therapy, human, Humans, procedures, treatment outcome, videoconferencing
@article{bouchard_moderating_2023,
title = {The moderating and mediating role of telepresence and cognitive change in cognitive behaviour therapy delivered via videoconference},
author = {S. Bouchard and M. Berthiaume and G. Robillard and M. Allard and I. Green-Demers and S. Watts and A. Marchand and P. Gosselin and F. Langlois and G. Belleville and M. J. Dugas},
url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-85139800809&doi=10.1002%2fcpp.2816&partnerID=40&md5=5eac58684326b5475037e1474aa932f7},
doi = {10.1002/cpp.2816},
issn = {10633995},
year = {2023},
date = {2023-01-01},
journal = {Clinical Psychology and Psychotherapy},
volume = {30},
number = {3},
pages = {575–586},
publisher = {John Wiley and Sons Ltd},
abstract = {In this study, we combined the results of two controlled trials and examined the relationships between working alliance, telepresence, cognitive change and treatment outcome. Sixty-five participants with a primary diagnosis of generalized anxiety disorder (GAD) or panic disorder with agoraphobia (PDA) received cognitive behaviour therapy delivered via videoconference. Participants completed measures of working alliance and telepresence after three psychotherapy sessions. They also completed measures of treatment outcome and dysfunctional beliefs (cognitive change) specific to PDA and GAD at pretreatment and posttreatment. Results revealed that telepresence at the fifth session moderated the relationship between the working alliance at the first and fifth sessions. As telepresence increased, its impact on the working alliance diminished. Cognitive change mediated the relationship between the working alliance at the fifth session and treatment outcome. © 2022 John Wiley & Sons Ltd.},
note = {Publisher: John Wiley and Sons Ltd},
keywords = {agoraphobia, Anxiety disorder, Anxiety Disorders, cognition, cognitive behavioral therapy, human, Humans, procedures, treatment outcome, videoconferencing},
pubstate = {published},
tppubtype = {article}
}
In this study, we combined the results of two controlled trials and examined the relationships between working alliance, telepresence, cognitive change and treatment outcome. Sixty-five participants with a primary diagnosis of generalized anxiety disorder (GAD) or panic disorder with agoraphobia (PDA) received cognitive behaviour therapy delivered via videoconference. Participants completed measures of working alliance and telepresence after three psychotherapy sessions. They also completed measures of treatment outcome and dysfunctional beliefs (cognitive change) specific to PDA and GAD at pretreatment and posttreatment. Results revealed that telepresence at the fifth session moderated the relationship between the working alliance at the first and fifth sessions. As telepresence increased, its impact on the working alliance diminished. Cognitive change mediated the relationship between the working alliance at the fifth session and treatment outcome. © 2022 John Wiley & Sons Ltd.
6.
Ikic, V.; Bélanger, C.; Bouchard, S.; Gosselin, P.; Langlois, F.; Labrecque, J.; Dugas, M. J.; Marchand, A.
Reduction in costs after treating comorbid panic disorder with agoraphobia and generalized anxiety disorder Article de journal
Dans: Journal of Mental Health Policy and Economics, vol. 20, no 1, p. 11–20, 2017, ISSN: 10914358, (Publisher: ICMPE).
Résumé | Liens | BibTeX | Étiquettes: adult, agoraphobia, Anxiety disorder, Anxiety Disorders, article, cognitive behavioral therapy, cognitive therapy, comorbidity, controlled study, dysthymia, economics, female, follow up, generalized anxiety disorder, health care cost, Health Care Costs, human, Humans, major clinical study, major depression, male, Mental health, obsessive compulsive disorder, panic, Panic Disorder, phobia, posttraumatic stress disorder, procedures, Quebec, social phobia, statistics and numerical data
@article{ikic_reduction_2017,
title = {Reduction in costs after treating comorbid panic disorder with agoraphobia and generalized anxiety disorder},
author = {V. Ikic and C. Bélanger and S. Bouchard and P. Gosselin and F. Langlois and J. Labrecque and M. J. Dugas and A. Marchand},
url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-85018690998&partnerID=40&md5=0d0600e6dd4e2a381f733ac063d639dc},
issn = {10914358},
year = {2017},
date = {2017-01-01},
journal = {Journal of Mental Health Policy and Economics},
volume = {20},
number = {1},
pages = {11–20},
publisher = {ICMPE},
abstract = {Background: Panic disorder with agoraphobia (PDA) and generalized anxiety disorder (GAD) are impairing and costly disorders that are often misdiagnosed and left untreated despite multiple consultations. These disorders frequently co-occur, but little is known about the costs associated with their comorbidity and the impact of cognitive-behavioral therapy (CBT) on cost reduction. Aims of the Study: The first objective of this study was to assess the mental health-related costs associated with the specific concomitance of PDA and GAD. The second aim was to determine whether there is a reduction in direct and indirect mental healthrelated costs following conventional CBT for the primary disorder only (PDA or GAD) or combined CBT adapted to the comorbidity (PDA and GAD). Methods: A total of 123 participants with a double diagnosis of PDA and GAD participated in this study. Direct and indirect mental health-related costs were assessed and calculated from a societal perspective at the pre-Test, the post-Test, and the three-month, sixmonth and one-year follow-ups. Results: At the pre-Test, PDA-GAD comorbidity was found to generate a mean total cost of CAD2,000.48 (SD = 2,069.62) per participant over a three-month period. The indirect costs were much higher than the direct costs. Both treatment modalities led to significant and similar decreases in all cost categories from the pretest to the post-Test. This reduction was maintained until the oneyear follow-up. Discussion: Methodological choices may have underestimated cost evaluations. Nonetheless, this study supports the cost offset effects of both conventional CBT for primary PDA or GAD and combined CBT for PDA-GAD comorbidity. Implications for Healthcare Provision and Use: Treatment of comorbid and costly disorders with evidence-based treatments such as CBT may lead to considerable economic benefits for society. Implications for Health Policies: Considering the limited resources of healthcare systems, it is important to make choices that will lead to better accessibility of quality services. The application of CBT for PDA, GAD or both disorders and training mental health professionals in this therapeutic approach should be encouraged. Additionally, it would be favorable for insurance plans to reimburse employees for expenses associated with psychological treatment for anxiety disorders. Implications for Further Research: In addition to symptom reduction, it would be of great pertinence to explore which factors can contribute to reducing direct and indirect mental health-related costs. © 2017 ICMPE.},
note = {Publisher: ICMPE},
keywords = {adult, agoraphobia, Anxiety disorder, Anxiety Disorders, article, cognitive behavioral therapy, cognitive therapy, comorbidity, controlled study, dysthymia, economics, female, follow up, generalized anxiety disorder, health care cost, Health Care Costs, human, Humans, major clinical study, major depression, male, Mental health, obsessive compulsive disorder, panic, Panic Disorder, phobia, posttraumatic stress disorder, procedures, Quebec, social phobia, statistics and numerical data},
pubstate = {published},
tppubtype = {article}
}
Background: Panic disorder with agoraphobia (PDA) and generalized anxiety disorder (GAD) are impairing and costly disorders that are often misdiagnosed and left untreated despite multiple consultations. These disorders frequently co-occur, but little is known about the costs associated with their comorbidity and the impact of cognitive-behavioral therapy (CBT) on cost reduction. Aims of the Study: The first objective of this study was to assess the mental health-related costs associated with the specific concomitance of PDA and GAD. The second aim was to determine whether there is a reduction in direct and indirect mental healthrelated costs following conventional CBT for the primary disorder only (PDA or GAD) or combined CBT adapted to the comorbidity (PDA and GAD). Methods: A total of 123 participants with a double diagnosis of PDA and GAD participated in this study. Direct and indirect mental health-related costs were assessed and calculated from a societal perspective at the pre-Test, the post-Test, and the three-month, sixmonth and one-year follow-ups. Results: At the pre-Test, PDA-GAD comorbidity was found to generate a mean total cost of CAD2,000.48 (SD = 2,069.62) per participant over a three-month period. The indirect costs were much higher than the direct costs. Both treatment modalities led to significant and similar decreases in all cost categories from the pretest to the post-Test. This reduction was maintained until the oneyear follow-up. Discussion: Methodological choices may have underestimated cost evaluations. Nonetheless, this study supports the cost offset effects of both conventional CBT for primary PDA or GAD and combined CBT for PDA-GAD comorbidity. Implications for Healthcare Provision and Use: Treatment of comorbid and costly disorders with evidence-based treatments such as CBT may lead to considerable economic benefits for society. Implications for Health Policies: Considering the limited resources of healthcare systems, it is important to make choices that will lead to better accessibility of quality services. The application of CBT for PDA, GAD or both disorders and training mental health professionals in this therapeutic approach should be encouraged. Additionally, it would be favorable for insurance plans to reimburse employees for expenses associated with psychological treatment for anxiety disorders. Implications for Further Research: In addition to symptom reduction, it would be of great pertinence to explore which factors can contribute to reducing direct and indirect mental health-related costs. © 2017 ICMPE.
7.
Ikic, V.; Bélanger, C.; Bouchard, S.; Gosselin, P.; Langlois, F.; Labrecque, J.; Dugas, M. J.; Marchand, A.
Reduction in costs after treating comorbid panic disorder with agoraphobia and generalized anxiety disorder Article de journal
Dans: Journal of Mental Health Policy and Economics, vol. 20, no 1, p. 11–20, 2017, ISSN: 10914358.
Résumé | Liens | BibTeX | Étiquettes: adult, agoraphobia, Anxiety disorder, Anxiety Disorders, article, cognitive behavioral therapy, cognitive therapy, comorbidity, controlled study, dysthymia, economics, female, follow up, generalized anxiety disorder, health care cost, Health Care Costs, human, Humans, major clinical study, major depression, male, Mental health, obsessive compulsive disorder, panic, Panic Disorder, phobia, posttraumatic stress disorder, procedures, Quebec, social phobia, statistics and numerical data
@article{ikicReductionCostsTreating2017,
title = {Reduction in costs after treating comorbid panic disorder with agoraphobia and generalized anxiety disorder},
author = {V. Ikic and C. Bélanger and S. Bouchard and P. Gosselin and F. Langlois and J. Labrecque and M. J. Dugas and A. Marchand},
url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-85018690998&partnerID=40&md5=0d0600e6dd4e2a381f733ac063d639dc},
issn = {10914358},
year = {2017},
date = {2017-01-01},
journal = {Journal of Mental Health Policy and Economics},
volume = {20},
number = {1},
pages = {11–20},
publisher = {ICMPE},
abstract = {Background: Panic disorder with agoraphobia (PDA) and generalized anxiety disorder (GAD) are impairing and costly disorders that are often misdiagnosed and left untreated despite multiple consultations. These disorders frequently co-occur, but little is known about the costs associated with their comorbidity and the impact of cognitive-behavioral therapy (CBT) on cost reduction. Aims of the Study: The first objective of this study was to assess the mental health-related costs associated with the specific concomitance of PDA and GAD. The second aim was to determine whether there is a reduction in direct and indirect mental healthrelated costs following conventional CBT for the primary disorder only (PDA or GAD) or combined CBT adapted to the comorbidity (PDA and GAD). Methods: A total of 123 participants with a double diagnosis of PDA and GAD participated in this study. Direct and indirect mental health-related costs were assessed and calculated from a societal perspective at the pre-Test, the post-Test, and the three-month, sixmonth and one-year follow-ups. Results: At the pre-Test, PDA-GAD comorbidity was found to generate a mean total cost of CAD2,000.48 (SD = 2,069.62) per participant over a three-month period. The indirect costs were much higher than the direct costs. Both treatment modalities led to significant and similar decreases in all cost categories from the pretest to the post-Test. This reduction was maintained until the oneyear follow-up. Discussion: Methodological choices may have underestimated cost evaluations. Nonetheless, this study supports the cost offset effects of both conventional CBT for primary PDA or GAD and combined CBT for PDA-GAD comorbidity. Implications for Healthcare Provision and Use: Treatment of comorbid and costly disorders with evidence-based treatments such as CBT may lead to considerable economic benefits for society. Implications for Health Policies: Considering the limited resources of healthcare systems, it is important to make choices that will lead to better accessibility of quality services. The application of CBT for PDA, GAD or both disorders and training mental health professionals in this therapeutic approach should be encouraged. Additionally, it would be favorable for insurance plans to reimburse employees for expenses associated with psychological treatment for anxiety disorders. Implications for Further Research: In addition to symptom reduction, it would be of great pertinence to explore which factors can contribute to reducing direct and indirect mental health-related costs. © 2017 ICMPE.},
keywords = {adult, agoraphobia, Anxiety disorder, Anxiety Disorders, article, cognitive behavioral therapy, cognitive therapy, comorbidity, controlled study, dysthymia, economics, female, follow up, generalized anxiety disorder, health care cost, Health Care Costs, human, Humans, major clinical study, major depression, male, Mental health, obsessive compulsive disorder, panic, Panic Disorder, phobia, posttraumatic stress disorder, procedures, Quebec, social phobia, statistics and numerical data},
pubstate = {published},
tppubtype = {article}
}
Background: Panic disorder with agoraphobia (PDA) and generalized anxiety disorder (GAD) are impairing and costly disorders that are often misdiagnosed and left untreated despite multiple consultations. These disorders frequently co-occur, but little is known about the costs associated with their comorbidity and the impact of cognitive-behavioral therapy (CBT) on cost reduction. Aims of the Study: The first objective of this study was to assess the mental health-related costs associated with the specific concomitance of PDA and GAD. The second aim was to determine whether there is a reduction in direct and indirect mental healthrelated costs following conventional CBT for the primary disorder only (PDA or GAD) or combined CBT adapted to the comorbidity (PDA and GAD). Methods: A total of 123 participants with a double diagnosis of PDA and GAD participated in this study. Direct and indirect mental health-related costs were assessed and calculated from a societal perspective at the pre-Test, the post-Test, and the three-month, sixmonth and one-year follow-ups. Results: At the pre-Test, PDA-GAD comorbidity was found to generate a mean total cost of CAD2,000.48 (SD = 2,069.62) per participant over a three-month period. The indirect costs were much higher than the direct costs. Both treatment modalities led to significant and similar decreases in all cost categories from the pretest to the post-Test. This reduction was maintained until the oneyear follow-up. Discussion: Methodological choices may have underestimated cost evaluations. Nonetheless, this study supports the cost offset effects of both conventional CBT for primary PDA or GAD and combined CBT for PDA-GAD comorbidity. Implications for Healthcare Provision and Use: Treatment of comorbid and costly disorders with evidence-based treatments such as CBT may lead to considerable economic benefits for society. Implications for Health Policies: Considering the limited resources of healthcare systems, it is important to make choices that will lead to better accessibility of quality services. The application of CBT for PDA, GAD or both disorders and training mental health professionals in this therapeutic approach should be encouraged. Additionally, it would be favorable for insurance plans to reimburse employees for expenses associated with psychological treatment for anxiety disorders. Implications for Further Research: In addition to symptom reduction, it would be of great pertinence to explore which factors can contribute to reducing direct and indirect mental health-related costs. © 2017 ICMPE.
8.
Cousineau, H.; Marchand, A.; Bouchard, S.; Bélanger, C.; Gosselin, P.; Langlois, F.; Labrecque, J.; Dugas, M. J.; Belleville, G.
Insomnia symptoms following treatment for comorbid panic disorder with agoraphobia and generalized anxiety disorder Article de journal
Dans: Journal of Nervous and Mental Disease, vol. 204, no 4, p. 267–273, 2016, ISSN: 00223018, (Publisher: Lippincott Williams and Wilkins).
Résumé | Liens | BibTeX | Étiquettes: adult, agoraphobia, antidepressant agent, Anxiety Disorders, anxiolytic agent, article, clinical trial, cognitive therapy, cohort analysis, Cohort Studies, Combined Modality Therapy, comorbidity, comparative study, controlled study, Depression, disease severity, female, generalized anxiety disorder, human, Humans, hypnotic agent, insomnia, major clinical study, male, Middle Aged, multicenter study, multimodality cancer therapy, nocturnal panic attack, panic, Panic Disorder, panic disorder with agoraphobia, patient worry, procedures, psychoeducation, psychology, psychotropic agent, Psychotropic Drugs, quasi experimental study, Quebec, randomized controlled trial, Sleep Initiation and Maintenance Disorders, statistical significance, treatment outcome, wakefulness, Young Adult
@article{cousineau_insomnia_2016,
title = {Insomnia symptoms following treatment for comorbid panic disorder with agoraphobia and generalized anxiety disorder},
author = {H. Cousineau and A. Marchand and S. Bouchard and C. Bélanger and P. Gosselin and F. Langlois and J. Labrecque and M. J. Dugas and G. Belleville},
url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-84962128029&doi=10.1097%2fNMD.0000000000000466&partnerID=40&md5=2ca2dd82c29553bd7377ba64dd5522cc},
doi = {10.1097/NMD.0000000000000466},
issn = {00223018},
year = {2016},
date = {2016-01-01},
journal = {Journal of Nervous and Mental Disease},
volume = {204},
number = {4},
pages = {267–273},
publisher = {Lippincott Williams and Wilkins},
abstract = {Patients with panic disorder with agoraphobia (PDA) or generalized anxiety disorder (GAD) frequently also suffer from insomnia. However, the impact of cognitive-behavioral therapy (CBT) for anxiety disorders on insomnia has been understudied. Furthermore, comorbidity between anxiety disorders is common. Our main objective was to assess the impact of CBT for PDA or GAD on insomnia. In a quasi-experimental design, 86 participants with PDA and GAD received conventional CBT for their primary disorder or combined CBT for both disorders. Overall, CBTs had a significant impact on reducing insomnia symptoms (η2 = 0.58). However, among people with insomnia at pretest (67%), 33% still had an insomnia diagnosis, and the majority (63%) had clinically significant residual insomnia following treatment. In conclusion, the CBTs had a positive effect on the reduction of insomnia, but a significant proportion of participants still had insomnia problems following treatment. Clinicians should address insomnia during CBT for PDA and GAD. Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.},
note = {Publisher: Lippincott Williams and Wilkins},
keywords = {adult, agoraphobia, antidepressant agent, Anxiety Disorders, anxiolytic agent, article, clinical trial, cognitive therapy, cohort analysis, Cohort Studies, Combined Modality Therapy, comorbidity, comparative study, controlled study, Depression, disease severity, female, generalized anxiety disorder, human, Humans, hypnotic agent, insomnia, major clinical study, male, Middle Aged, multicenter study, multimodality cancer therapy, nocturnal panic attack, panic, Panic Disorder, panic disorder with agoraphobia, patient worry, procedures, psychoeducation, psychology, psychotropic agent, Psychotropic Drugs, quasi experimental study, Quebec, randomized controlled trial, Sleep Initiation and Maintenance Disorders, statistical significance, treatment outcome, wakefulness, Young Adult},
pubstate = {published},
tppubtype = {article}
}
Patients with panic disorder with agoraphobia (PDA) or generalized anxiety disorder (GAD) frequently also suffer from insomnia. However, the impact of cognitive-behavioral therapy (CBT) for anxiety disorders on insomnia has been understudied. Furthermore, comorbidity between anxiety disorders is common. Our main objective was to assess the impact of CBT for PDA or GAD on insomnia. In a quasi-experimental design, 86 participants with PDA and GAD received conventional CBT for their primary disorder or combined CBT for both disorders. Overall, CBTs had a significant impact on reducing insomnia symptoms (η2 = 0.58). However, among people with insomnia at pretest (67%), 33% still had an insomnia diagnosis, and the majority (63%) had clinically significant residual insomnia following treatment. In conclusion, the CBTs had a positive effect on the reduction of insomnia, but a significant proportion of participants still had insomnia problems following treatment. Clinicians should address insomnia during CBT for PDA and GAD. Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.
9.
Cousineau, H.; Marchand, A.; Bouchard, S.; Bélanger, C.; Gosselin, P.; Langlois, F.; Labrecque, J.; Dugas, M. J.; Belleville, G.
Insomnia symptoms following treatment for comorbid panic disorder with agoraphobia and generalized anxiety disorder Article de journal
Dans: Journal of Nervous and Mental Disease, vol. 204, no 4, p. 267–273, 2016, ISSN: 00223018.
Résumé | Liens | BibTeX | Étiquettes: adult, agoraphobia, antidepressant agent, Anxiety Disorders, anxiolytic agent, article, clinical trial, cognitive therapy, cohort analysis, Cohort Studies, Combined Modality Therapy, comorbidity, comparative study, controlled study, Depression, disease severity, female, generalized anxiety disorder, human, Humans, hypnotic agent, insomnia, major clinical study, male, Middle Aged, multicenter study, multimodality cancer therapy, nocturnal panic attack, panic, Panic Disorder, panic disorder with agoraphobia, patient worry, procedures, psychoeducation, psychology, psychotropic agent, Psychotropic Drugs, quasi experimental study, Quebec, randomized controlled trial, Sleep Initiation and Maintenance Disorders, statistical significance, treatment outcome, wakefulness, Young Adult
@article{cousineauInsomniaSymptomsFollowing2016,
title = {Insomnia symptoms following treatment for comorbid panic disorder with agoraphobia and generalized anxiety disorder},
author = {H. Cousineau and A. Marchand and S. Bouchard and C. Bélanger and P. Gosselin and F. Langlois and J. Labrecque and M. J. Dugas and G. Belleville},
url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-84962128029&doi=10.1097%2fNMD.0000000000000466&partnerID=40&md5=2ca2dd82c29553bd7377ba64dd5522cc},
doi = {10.1097/NMD.0000000000000466},
issn = {00223018},
year = {2016},
date = {2016-01-01},
journal = {Journal of Nervous and Mental Disease},
volume = {204},
number = {4},
pages = {267–273},
publisher = {Lippincott Williams and Wilkins},
abstract = {Patients with panic disorder with agoraphobia (PDA) or generalized anxiety disorder (GAD) frequently also suffer from insomnia. However, the impact of cognitive-behavioral therapy (CBT) for anxiety disorders on insomnia has been understudied. Furthermore, comorbidity between anxiety disorders is common. Our main objective was to assess the impact of CBT for PDA or GAD on insomnia. In a quasi-experimental design, 86 participants with PDA and GAD received conventional CBT for their primary disorder or combined CBT for both disorders. Overall, CBTs had a significant impact on reducing insomnia symptoms (η2 = 0.58). However, among people with insomnia at pretest (67%), 33% still had an insomnia diagnosis, and the majority (63%) had clinically significant residual insomnia following treatment. In conclusion, the CBTs had a positive effect on the reduction of insomnia, but a significant proportion of participants still had insomnia problems following treatment. Clinicians should address insomnia during CBT for PDA and GAD. Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.},
keywords = {adult, agoraphobia, antidepressant agent, Anxiety Disorders, anxiolytic agent, article, clinical trial, cognitive therapy, cohort analysis, Cohort Studies, Combined Modality Therapy, comorbidity, comparative study, controlled study, Depression, disease severity, female, generalized anxiety disorder, human, Humans, hypnotic agent, insomnia, major clinical study, male, Middle Aged, multicenter study, multimodality cancer therapy, nocturnal panic attack, panic, Panic Disorder, panic disorder with agoraphobia, patient worry, procedures, psychoeducation, psychology, psychotropic agent, Psychotropic Drugs, quasi experimental study, Quebec, randomized controlled trial, Sleep Initiation and Maintenance Disorders, statistical significance, treatment outcome, wakefulness, Young Adult},
pubstate = {published},
tppubtype = {article}
}
Patients with panic disorder with agoraphobia (PDA) or generalized anxiety disorder (GAD) frequently also suffer from insomnia. However, the impact of cognitive-behavioral therapy (CBT) for anxiety disorders on insomnia has been understudied. Furthermore, comorbidity between anxiety disorders is common. Our main objective was to assess the impact of CBT for PDA or GAD on insomnia. In a quasi-experimental design, 86 participants with PDA and GAD received conventional CBT for their primary disorder or combined CBT for both disorders. Overall, CBTs had a significant impact on reducing insomnia symptoms (η2 = 0.58). However, among people with insomnia at pretest (67%), 33% still had an insomnia diagnosis, and the majority (63%) had clinically significant residual insomnia following treatment. In conclusion, the CBTs had a positive effect on the reduction of insomnia, but a significant proportion of participants still had insomnia problems following treatment. Clinicians should address insomnia during CBT for PDA and GAD. Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.
10.
Perreault, M.; Bouchard, S.; Lapalme, M.; Laverdure, A.; Audet, D.; Cusson, J. -C.; Zacchia, C.; Milton, D.; Tion, M. S.; Chartier-Otis, M.; Marchand, A.; Bélanger, C.
Dans: Sante Mentale au Quebec, vol. 40, no 1, p. 35–51, 2015, ISSN: 03836320, (Publisher: Revue Sante Mentale au Quebec SMQ).
Résumé | Liens | BibTeX | Étiquettes: agoraphobia, Canada, female, human, Humans, male, Panic Disorder, peer group, Quebec, self help, Self-Help Groups
@article{perreault_perspective_2015,
title = {Perspective of peer helpers regarding their experience animating a self-treatment program for panic disorders [Perspective de pairs aidants sur leur expérience d’animation d’un programme d’autotraitement du trouble panique]},
author = {M. Perreault and S. Bouchard and M. Lapalme and A. Laverdure and D. Audet and J. -C. Cusson and C. Zacchia and D. Milton and M. S. Tion and M. Chartier-Otis and A. Marchand and C. Bélanger},
url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-84945341002&doi=10.7202%2f1032381ar&partnerID=40&md5=44a912fa4c8a0c927f7f1bf70d0381d7},
doi = {10.7202/1032381ar},
issn = {03836320},
year = {2015},
date = {2015-01-01},
journal = {Sante Mentale au Quebec},
volume = {40},
number = {1},
pages = {35–51},
publisher = {Revue Sante Mentale au Quebec SMQ},
abstract = {Objective: Support groups can help to reach individuals with anxiety disorders who are not or are only partly obtaining health services. The present study is based on a program that involves peer helpers as animators of a selftreatment group (Zéro-ATAQ). Their perspective has been documented in order to identify the aspects of the program which can be improved. Methods: Eleven peer helpers led the 12 sessions of the program, which was dispensed in four regions of Quebec for 32 persons having panic disorders with agoraphobia. The perspectives of ten peer animators were documented based on a semi-structured interview that took place at the end of the program, and a focus group that was held over six months later with peer animators from each of the groups. Their comments were transcribed and a thematic content analysis was conducted. Results: All of the peer helper animators reported that they enjoyed participating in the program, that they appreciated being able to help others having an anxiety disorder, and that the program helped them in their role as animators of these types of activities. Nearly all of the peer helpers emphasized the importance of being able to count on the supervision of a professional when needed. Conclusion: This study revealed (1) the feasibility of implementing a program of this kind in partnership with peers, (2) the qualifications necessary to lead this type of program, (3) the requirements in terms of training and available material, and (4) the importance of supervision. © Département de psychiatrie de l’Université de Montréal, 2015.},
note = {Publisher: Revue Sante Mentale au Quebec SMQ},
keywords = {agoraphobia, Canada, female, human, Humans, male, Panic Disorder, peer group, Quebec, self help, Self-Help Groups},
pubstate = {published},
tppubtype = {article}
}
Objective: Support groups can help to reach individuals with anxiety disorders who are not or are only partly obtaining health services. The present study is based on a program that involves peer helpers as animators of a selftreatment group (Zéro-ATAQ). Their perspective has been documented in order to identify the aspects of the program which can be improved. Methods: Eleven peer helpers led the 12 sessions of the program, which was dispensed in four regions of Quebec for 32 persons having panic disorders with agoraphobia. The perspectives of ten peer animators were documented based on a semi-structured interview that took place at the end of the program, and a focus group that was held over six months later with peer animators from each of the groups. Their comments were transcribed and a thematic content analysis was conducted. Results: All of the peer helper animators reported that they enjoyed participating in the program, that they appreciated being able to help others having an anxiety disorder, and that the program helped them in their role as animators of these types of activities. Nearly all of the peer helpers emphasized the importance of being able to count on the supervision of a professional when needed. Conclusion: This study revealed (1) the feasibility of implementing a program of this kind in partnership with peers, (2) the qualifications necessary to lead this type of program, (3) the requirements in terms of training and available material, and (4) the importance of supervision. © Département de psychiatrie de l’Université de Montréal, 2015.